IgE-mediated mast cell responses are inhibited by thymol-mediated, activation-induced cell death in skin inflammation
- 1 June 2014
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 133 (6) , 1735-1743
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Abundant immunoglobulin E‐positive cells in skin lesions support an allergic etiology of atopic dermatitis in the elderlyJournal of the European Academy of Dermatology and Venereology, 2012
- Effects of Thymol on B16-F10 Melanoma CellsJournal of Agricultural and Food Chemistry, 2012
- Effect of thymol on peripheral blood mononuclear cell PBMC and acute promyelotic cancer cell line HL-60Chemico-Biological Interactions, 2011
- TRPA1 Contributes to Cold HypersensitivityThe Journal of Neuroscience, 2010
- IL-33 Is Produced by Mast Cells and Regulates IgE-Dependent InflammationPLOS ONE, 2010
- Impairing oral tolerance promotes allergy and anaphylaxis: A new murine food allergy modelJournal of Allergy and Clinical Immunology, 2009
- Thymol and related alkyl phenols activate the hTRPA1 channelBritish Journal of Pharmacology, 2008
- Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritisJournal of Experimental Medicine, 2007
- Efficacy of anti-IgE therapy in patients with atopic dermatitisJournal of the American Academy of Dermatology, 2006
- Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritisAnnals of the Rheumatic Diseases, 2005